 |
PDBsum entry 1v49
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Structural protein
|
PDB id
|
|
|
|
1v49
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Biol Chem
280:24610-24617
(2005)
|
|
PubMed id:
|
|
|
|
|
| |
|
Solution structure of microtubule-associated protein light chain 3 and identification of its functional subdomains.
|
|
T.Kouno,
M.Mizuguchi,
I.Tanida,
T.Ueno,
T.Kanematsu,
Y.Mori,
H.Shinoda,
M.Hirata,
E.Kominami,
K.Kawano.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Microtubule-associated protein (MAP) light chain 3 (LC3) is a human homologue of
yeast Apg8/Aut7/Cvt5 (Atg8), which is essential for autophagy. MAP-LC3 is
cleaved by a cysteine protease to produce LC3-I, which is located in cytosolic
fraction. LC3-I, in turn, is converted to LC3-II through the actions of E1- and
E2-like enzymes. LC3-II is covalently attached to phosphatidylethanolamine on
its C terminus, and it binds tightly to autophagosome membranes. We determined
the solution structure of LC3-I and found that it is divided into N- and
C-terminal subdomains. Additional analysis using a photochemically induced
dynamic nuclear polarization technique also showed that the N-terminal subdomain
of LC3-I makes contact with the surface of the C-terminal subdomain and that
LC3-I adopts a single compact conformation in solution. Moreover, the addition
of dodecylphosphocholine into the LC3-I solution induced chemical shift
perturbations primarily in the C-terminal subdomain, which implies that the two
subdomains have different sensitivities to dodecylphosphocholine micelles. On
the other hand, deletion of the N-terminal subdomain abolished binding of
tubulin and microtubules. Thus, we showed that two subdomains of the LC3-I
structure have distinct functions, suggesting that MAP-LC3 can act as an adaptor
protein between microtubules and autophagosomes.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
FIG. 1. Solution structure of the unmodified form of
MAP-LC3 (LC3-I). A, stereo view of the backbone heavy atom (N, C
,
and C') traces of 15 superimposed structures of LC3-I obtained
from the structure calculations. The N-terminal (residues 1 to
29) and C-terminal (residues 30 to 120) subdomains are shown in
green and blue, respectively. B, ribbon presentation of the
energy-minimized average structure of LC3-I. The representation
is oriented as in panel A. All tyrosine (Tyr-38, Tyr-99,
Tyr-110, and Tyr-113) and histidine (His-27, His-57, and His-86)
residues in LC3-I are shown as ball-and-stick representations.
Residues Ile-34, Ile-35, and Ile-67 include ^1H resonances
showing the upfield shift.
|
 |
Figure 4.
FIG. 4. Binding assays of wild-type LC3-I and the mutant,
LC3-I N. A, surface plasmon
resonance study of tubulin binding by LC3-I. For both LC3-I
(left) and LC3-I N (right), samples of
various concentrations (2.5, 5.0, 7.5, and 10 µM) were
injected over immobilized tubulin. The inset shows the
sensorgrams when 400 mM NaCl was injected into the flow cells.
B, co-sedimentation assay of LC3-I and LC3-I N with
tubulin-polymerized microtubules. Wild-type LC3-I (lane 1) or
LC3-I N(lane 2) proteins were
incubated with microtubules and subjected to centrifugation.
Sedimented proteins were analyzed by SDS-PAGE. As a control, a
binding assay between LC3-I and microtubules was performed in
the presence of 400 mM NaCl (lane 3). Positions of bands for
tubulin, LC3-I, and LC3-I N are indicated by
arrowheads.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(2005,
280,
24610-24617)
copyright 2005.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
K.R.Drake,
M.Kang,
and
A.K.Kenworthy
(2010).
Nucleocytoplasmic distribution and dynamics of the autophagosome marker EGFP-LC3.
|
| |
PLoS One,
5,
e9806.
|
 |
|
|
|
|
 |
S.J.Cherra,
S.M.Kulich,
G.Uechi,
M.Balasubramani,
J.Mountzouris,
B.W.Day,
and
C.T.Chu
(2010).
Regulation of the autophagy protein LC3 by phosphorylation.
|
| |
J Cell Biol,
190,
533-539.
|
 |
|
|
|
|
 |
I.Monastyrska,
E.Rieter,
D.J.Klionsky,
and
F.Reggiori
(2009).
Multiple roles of the cytoskeleton in autophagy.
|
| |
Biol Rev Camb Philos Soc,
84,
431-448.
|
 |
|
|
|
|
 |
L.Baisamy,
S.Cavin,
N.Jurisch,
and
D.Diviani
(2009).
The ubiquitin-like protein LC3 regulates the Rho-GEF activity of AKAP-Lbc.
|
| |
J Biol Chem,
284,
28232-28242.
|
 |
|
|
|
|
 |
L.Du,
R.W.Hickey,
H.Bayir,
S.C.Watkins,
V.A.Tyurin,
F.Guo,
P.M.Kochanek,
L.W.Jenkins,
J.Ren,
G.Gibson,
C.T.Chu,
V.E.Kagan,
and
R.S.Clark
(2009).
Starving neurons show sex difference in autophagy.
|
| |
J Biol Chem,
284,
2383-2396.
|
 |
|
|
|
|
 |
Z.Liu,
R.K.Meray,
T.N.Grammatopoulos,
R.A.Fredenburg,
M.R.Cookson,
Y.Liu,
T.Logan,
and
P.T.Lansbury
(2009).
Membrane-associated farnesylated UCH-L1 promotes alpha-synuclein neurotoxicity and is a therapeutic target for Parkinson's disease.
|
| |
Proc Natl Acad Sci U S A,
106,
4635-4640.
|
 |
|
|
|
|
 |
D.Zhou,
and
S.A.Spector
(2008).
Human immunodeficiency virus type-1 infection inhibits autophagy.
|
| |
AIDS,
22,
695-699.
|
 |
|
|
|
|
 |
H.Y.Li,
and
X.F.Zhou
(2008).
Potential conversion of adult clavicle-derived chondrocytes into neural lineage cells in vitro.
|
| |
J Cell Physiol,
214,
630-644.
|
 |
|
|
|
|
 |
L.Jahreiss,
F.M.Menzies,
and
D.C.Rubinsztein
(2008).
The itinerary of autophagosomes: from peripheral formation to kiss-and-run fusion with lysosomes.
|
| |
Traffic,
9,
574-587.
|
 |
|
|
|
|
 |
S.Kimura,
T.Noda,
and
T.Yoshimori
(2008).
Dynein-dependent movement of autophagosomes mediates efficient encounters with lysosomes.
|
| |
Cell Struct Funct,
33,
109-122.
|
 |
|
|
|
|
 |
Y.B.Zhang,
S.X.Li,
X.P.Chen,
L.Yang,
Y.G.Zhang,
R.Liu,
and
L.Y.Tao
(2008).
Autophagy is activated and might protect neurons from degeneration after traumatic brain injury.
|
| |
Neurosci Bull,
24,
143-149.
|
 |
|
|
|
|
 |
Y.Lai,
R.W.Hickey,
Y.Chen,
H.Bayir,
M.L.Sullivan,
C.T.Chu,
P.M.Kochanek,
C.E.Dixon,
L.W.Jenkins,
S.H.Graham,
S.C.Watkins,
and
R.S.Clark
(2008).
Autophagy is increased after traumatic brain injury in mice and is partially inhibited by the antioxidant gamma-glutamylcysteinyl ethyl ester.
|
| |
J Cereb Blood Flow Metab,
28,
540-550.
|
 |
|
|
|
|
 |
A.Simonsen,
R.C.Cumming,
K.Lindmo,
V.Galaviz,
S.Cheng,
T.E.Rusten,
and
K.D.Finley
(2007).
Genetic modifiers of the Drosophila blue cheese gene link defects in lysosomal transport with decreased life span and altered ubiquitinated-protein profiles.
|
| |
Genetics,
176,
1283-1297.
|
 |
|
|
|
|
 |
A.Hamacher-Brady,
N.R.Brady,
and
R.A.Gottlieb
(2006).
The interplay between pro-death and pro-survival signaling pathways in myocardial ischemia/reperfusion injury: apoptosis meets autophagy.
|
| |
Cardiovasc Drugs Ther,
20,
445-462.
|
 |
|
|
|
|
 |
R.L.Rich,
and
D.G.Myszka
(2006).
Survey of the year 2005 commercial optical biosensor literature.
|
| |
J Mol Recognit,
19,
478-534.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
');
}
}
 |